FY2017 EPS Estimates for Mead Johnson Nutrition Company Decreased by Gabelli (MJN)

FY2017 EPS Estimates for Mead Johnson Nutrition Company Decreased by Gabelli (MJN)

Mead Johnson Nutrition Company (NYSE:MJN) – Equities research analysts at Gabelli reduced their FY2017 earnings estimates for shares of Mead Johnson Nutrition Company in a research report issued on Friday. Gabelli analyst J. Gabelli now forecasts that the firm will earn $3.25 per share for the year, down from their prior forecast of $3.55. Gabelli also issued estimates for Mead Johnson Nutrition Company’s FY2018 earnings at $3.50 EPS and FY2019 earnings at $3.80 EPS.

A number of other equities research analysts have also recently commented on MJN. Berenberg Bank upgraded shares of Mead Johnson Nutrition Company from a “sell” rating to a “hold” rating and set a $66.00 target price on the stock in a research note on Thursday. Deutsche Bank AG restated a “hold” rating and set a $88.00 target price (up previously from $85.00) on shares of Mead Johnson Nutrition Company in a research note on Friday, October 21st. cut shares of Mead Johnson Nutrition Company from an “outperform” rating to an “underperform” rating and set a $77.00 target price on the stock. in a research note on Friday, October 28th. J P Morgan Chase & Co cut shares of Mead Johnson Nutrition Company from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $90.00 to $75.00 in a research note on Friday, October 28th. Finally, Citigroup Inc. restated a “buy” rating and set a $90.00 target price on shares of Mead Johnson Nutrition Company in a research note on Tuesday, November 1st. Two analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $86.50.

Shares of Mead Johnson Nutrition Company (NYSE:MJN) opened at 84.08 on Monday. The stock has a market capitalization of $15.50 billion, a PE ratio of 28.79 and a beta of 1.38. The firm has a 50-day moving average price of $72.69 and a 200 day moving average price of $78.04. Mead Johnson Nutrition Company has a one year low of $66.66 and a one year high of $94.40.

Mead Johnson Nutrition Company (NYSE:MJN) last issued its earnings results on Thursday, January 26th. The company reported $0.78 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by $0.03. The company earned $901.60 million during the quarter, compared to analysts’ expectations of $928.84 million. Mead Johnson Nutrition Company had a net margin of 14.56% and a negative return on equity of 125.35%. The firm’s quarterly revenue was down 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.78 earnings per share.

Several hedge funds and other institutional investors have recently bought and sold shares of MJN. American Century Companies Inc. raised its position in Mead Johnson Nutrition Company by 15.2% in the second quarter. American Century Companies Inc. now owns 5,544,545 shares of the company’s stock worth $503,167,000 after buying an additional 732,011 shares during the period. ING Groep NV raised its position in Mead Johnson Nutrition Company by 56.1% in the second quarter. ING Groep NV now owns 6,630 shares of the company’s stock worth $602,000 after buying an additional 2,382 shares during the period. Emerald Advisers Inc. PA raised its position in Mead Johnson Nutrition Company by 43.2% in the second quarter. Emerald Advisers Inc. PA now owns 23,889 shares of the company’s stock worth $2,168,000 after buying an additional 7,212 shares during the period. Enterprise Financial Services Corp raised its position in Mead Johnson Nutrition Company by 21,645.5% in the second quarter. Enterprise Financial Services Corp now owns 2,392 shares of the company’s stock worth $217,000 after buying an additional 2,381 shares during the period. Finally, Nordea Investment Management AB raised its position in Mead Johnson Nutrition Company by 3.7% in the second quarter. Nordea Investment Management AB now owns 609,915 shares of the company’s stock worth $55,350,000 after buying an additional 22,012 shares during the period. 95.05% of the stock is owned by hedge funds and other institutional investors.

About Mead Johnson Nutrition Company

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Related posts

Leave a Comment